Innovative Eyewear, Inc. Announces Exercise of Warrants for $2.6 Million Gross Proceeds
Prnewswire· 2024-09-23 20:00
MIAMI, Sept. 23, 2024 /PRNewswire/ -- Innovative Eyewear, Inc. ("Innovative Eyewear" or the "Company") (Nasdaq: LUCY), the developer of smart eyewear under the Lucyd®, Nautica®, Eddie Bauer® and Reebok® brands, today announced the entry into definitive agreements for the immediate exercise of certain outstanding warrants to purchase an aggregate of 263,160 shares of the Company's common stock originally issued by the Company on May 29, 2024, each having an original exercise price of $9.50 per share, at an e ...
MINISO to Acquire Stake in Yonghui Superstores, a Leading Chinese Retailer
Prnewswire· 2024-09-23 20:00
文章核心观点 - 明星集团宣布以约63亿人民币收购永辉超市29.4%的股权,成为永辉最大单一股东 [1][2][3][4] - 永辉是中国领先的零售连锁企业,在中国拥有约850家超市,主营新鲜农产品和日用品 [2] - 明星集团希望通过此次收购,与永辉在产品开发、渠道升级和供应链等方面进行协同,实现协同效应和创造价值 [5] - 明星集团表示,此次交易有助于公司拓展到必需品领域,实现业务多元化,降低周期性风险 [5] 根据相关目录分别进行总结 交易概况 - 明星集团通过全资子公司广东骏彩国际贸易有限公司,以每股2.35元人民币的价格收购永辉29.4%的股权 [3][4] - 交易对价约63亿人民币,较永辉9月20日收盘价溢价3.1% [4] - 交易预计于2025年上半年完成,需获得监管部门批准和公司股东大会批准 [6] 交易背景 - 永辉是中国领先的零售连锁企业,2023年营收约786亿人民币 [2] - 永辉是中国最早将新鲜农产品引入现代超市的企业之一,在销售规模方面近年来一直位居中国百强超市第二 [2] - 交易对手包括Dairy Farm、京东和苏州汉邦投资 [3] 交易目的 - 明星集团希望通过此次收购,与永辉在产品开发、渠道升级和供应链等方面进行协同,实现协同效应和创造价值 [5] - 此次交易有助于明星集团拓展到必需品领域,实现业务多元化,降低周期性风险 [5] - 明星集团表示,仍将继续保持对现有业务的信心和投入,实现未来5年内核心业务不低于20%的复合年增长率 [5]
Moleculin Announces Positive In Vivo Efficacy Data of Annamycin in Orthotopic and Experimental Lung Metastatic Models of Sarcoma
Prnewswire· 2024-09-23 20:00
Data recently presented at the International Association for the Study of Lung Cancer (IASLC) 2024 World Conference on Lung CancerTreatment with Annamycin results in statistically significant inhibition of tumor growth and extension of survival in orthotopic lung cancer modelsAnnamycin continues to be 100% non-cardiotoxicHOUSTON, Sept. 23, 2024 /PRNewswire/ -- Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company with a broad portfolio of drug candid ...
Nano Labs Enters into Agreements with Shareholders to Convert Loans into Ordinary Shares
Prnewswire· 2024-09-23 20:00
HANGZHOU, China, Sept. 23, 2024 /PRNewswire/ -- Nano Labs Ltd (Nasdaq: NA) ("we," "the Company," or "Nano Labs"), a leading fabless integrated circuit design company and product solution provider in China, announced today that it entered into agreements with Mr. Jianping Kong, its chairman and chief executive officer, and Mr. Qifeng Sun, its vice chairman, along with their respective affiliates (the "Lenders") on September 20, 2023, to convert the interest-free loans from the Lenders in an aggregated amount ...
4DMT Announces Presentation at the 2024 North American Cystic Fibrosis Conference
GlobeNewswire News Room· 2024-09-23 20:00
EMERYVILLE, Calif., Sept. 23, 2024 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading clinical-stage genetic medicines company focused on unlocking the full potential of genetic medicines to treat large market diseases, today announced a poster presentation at the 2024 North American Cystic Fibrosis Conference (NACFC) in Boston, Massachusetts on September 26-28, 2024. 2024 NACFC Poster Presentation Details: Title:Transgene expression and CFTR channel function in hum ...
Gorilla Technology and CS Energy Form AI-Powered Strategic Partnership to Accelerate the Rise of Smart & Green Cities Across Thailand and Southeast Asia
Newsfile· 2024-09-23 20:00
Gorilla Technology and CS Energy Form AI-Powered Strategic Partnership to Accelerate the Rise of Smart & Green Cities Across Thailand and Southeast AsiaSeptember 23, 2024 8:00 AM EDT | Source: Gorilla Technology Group Inc.Bangkok, Thailand--(Newsfile Corp. - September 23, 2024) - Gorilla Technology Group Inc. (NASDAQ: GRRR) ("Gorilla" or the "Company") and CS Energy Technology Co., Ltd., one of Asia's leading energy infrastructure providers, have announced a strategic cooperation agreement. Th ...
Theriva™ Biologics Achieves Target Patient Enrollment in the VIRAGE Phase 2b Trial of VCN-01 with Gemcitabine/nab-Paclitaxel for the Treatment of Metastatic Pancreatic Cancer
GlobeNewswire News Room· 2024-09-23 20:00
- Target of 92 evaluable patients (46 in each of the control and VCN-01 treatment arms) enrolled across 15 sites in Spain and the USA within 21 months – ROCKVILLE, Md., Sept. 23, 2024 (GLOBE NEWSWIRE) -- Theriva™ Biologics, Inc. (NYSE American: TOVX), (“Theriva” or the “Company”), a diversified clinical-stage company developing therapeutics designed to treat cancer and related diseases in areas of high unmet need, today announced that it has achieved their target patient enrollment in the VIRAGE Phase 2b cl ...
airBaltic and RTX's Pratt & Whitney Unveil Long-Term Engine Maintenance Deal
Prnewswire· 2024-09-23 20:00
GTF maintenance agreement supports airline's growth plans EAST HARTFORD, Conn., Sept. 23, 2024 /PRNewswire/ -- Latvian national airline airBaltic and Pratt & Whitney have announced a long-term EngineWise™ Comprehensive maintenance services agreement for the airline's GTF engine fleet. This agreement links airBaltic's maintenance costs to the utilization of the airline's engines. Pratt & Whitney is an RTX (NYSE: RTX) business."Pratt & Whitney has been a long-term, trusted collaborator of airBaltic since we b ...
IBM and NASA Release Open-Source AI Model on Hugging Face for Weather and Climate Applications
Prnewswire· 2024-09-23 20:00
New AI foundation model offers insights beyond forecasting for scientists, developers, and businesses to better understand and analyze weather and climate dataYORKTOWN HEIGHTS, N.Y., Sept. 23, 2024 /PRNewswire/ -- IBM (NYSE: IBM) today announced a new AI foundation model for a variety of weather and climate use cases, available in open-source to the scientific, developer, and business communities. Developed by IBM and NASA, with contributions from Oak Ridge National Laboratory, the model offers a flexible, ...
Major Envoy Medical Investor Glen Taylor Discusses How Apple's AirPods Pro 2 Hearing Aid Announcement is a Potentially Positive Development for the Company
GlobeNewswire News Room· 2024-09-23 20:00
During “The Claman Countdown,” the billionaire investor and entrepreneur noted how hearing aid modes in next-gen wireless earbuds can work with Envoy Medical’s fully implanted hearing devices WHITE BEAR LAKE, Minnesota, Sept. 23, 2024 (GLOBE NEWSWIRE) -- Envoy Medical®, Inc. (“Envoy Medical”) (Nasdaq: “COCH”), a hearing health company focused on fully implanted hearing systems, today highlights an interview with key investor Glen Taylor on Fox Business News “The Claman Countdown” in which he commented on t ...